UroGen Pharma Ltd. Increase (Decrease) in Other Current Liabilities
UroGen Pharma Ltd. (URGN) reported Increase (Decrease) in Other Current Liabilities of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentLiabilities · last filed 2026-08-05
- UroGen Pharma Ltd. increase (decrease) in other current liabilities for the quarter ending 2026-06-30 was $0.00.
- UroGen Pharma Ltd. increase (decrease) in other current liabilities for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- UroGen Pharma Ltd. increase (decrease) in other current liabilities for the quarter ending 2025-12-31 was -$1.00K, a 100.50% decline year-over-year.
- UroGen Pharma Ltd. increase (decrease) in other current liabilities for the quarter ending 2025-09-30 was -$263.00K.
- UroGen Pharma Ltd. increase (decrease) in other current liabilities for fiscal 2025 was -$202.00K, a 201.00% decline from fiscal 2024.
- UroGen Pharma Ltd. increase (decrease) in other current liabilities for fiscal 2024 was $200.00K.
- UroGen Pharma Ltd. increase (decrease) in other current liabilities for fiscal 2023 was $0.00.
- UroGen Pharma Ltd. increase (decrease) in other current liabilities for fiscal 2022 was -$703.00K, a 1595.74% decline from fiscal 2021.
| Period end | Increase (Decrease) in Other Current Liabilities 3 month | Increase (Decrease) in Other Current Liabilities 6 month | Increase (Decrease) in Other Current Liabilities 9 month | Increase (Decrease) in Other Current Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $0.00 10-Q · filed 2026-08-05 | -$1.00K derived: sum of 3 quarters · filed 2026-08-05 | -$264.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-06 | -$1.00K derived: sum of 2 quarters · filed 2026-05-06 | -$264.00K derived: sum of 3 quarters · filed 2026-05-06 | -$685.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$264.00K derived: sum of 2 quarters · filed 2026-03-02 | -$685.00K derived: sum of 3 quarters · filed 2026-08-05 | -$202.00K 10-K · filed 2026-03-02 |
| 2025-09-30 | -$263.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$684.00K derived: sum of 2 quarters · filed 2026-08-05 | -$201.00K 10-Q · filed 2025-11-06 | -$1.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$421.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $62.00K 10-Q · filed 2026-08-05 | $262.00K derived: sum of 3 quarters · filed 2026-08-05 | $262.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $483.00K 10-Q · filed 2026-05-06 | $683.00K derived: sum of 2 quarters · filed 2026-05-06 | $683.00K derived: sum of 3 quarters · filed 2026-05-06 | $683.00K derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $200.00K derived: sum of 2 quarters · filed 2026-03-02 | $200.00K derived: sum of 3 quarters · filed 2026-03-02 | $200.00K 10-K · filed 2026-03-02 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2025-11-06 | $0.00 10-Q · filed 2025-11-06 | $0.00 derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $0.00 10-Q · filed 2025-08-07 | $0.00 derived: sum of 3 quarters · filed 2025-08-07 | $0.00 derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-12 | $0.00 derived: sum of 2 quarters · filed 2025-05-12 | $0.00 derived: sum of 3 quarters · filed 2025-05-12 | $0.00 derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | $0.00 derived: sum of 2 quarters · filed 2025-03-10 | $0.00 derived: sum of 3 quarters · filed 2025-03-10 | $0.00 10-K · filed 2025-03-10 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $0.00 derived: sum of 2 quarters · filed 2023-11-14 | $0.00 10-Q · filed 2023-11-14 | $1.00K derived: sum of 4 quarters · filed 2024-03-14 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $0.00 10-Q · filed 2023-08-10 | $1.00K derived: sum of 3 quarters · filed 2024-03-14 | $1.00K derived: sum of 4 quarters · filed 2024-03-14 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-11 | $1.00K derived: sum of 2 quarters · filed 2024-03-14 | $1.00K derived: sum of 3 quarters · filed 2024-03-14 | -$1.00M derived: sum of 4 quarters · filed 2024-03-14 |
| 2022-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $1.00K derived: sum of 2 quarters · filed 2024-03-14 | -$1.00M derived: sum of 3 quarters · filed 2024-03-14 | -$703.00K 10-K · filed 2024-03-14 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$1.00M derived: sum of 2 quarters · filed 2023-11-14 | -$704.00K 10-Q · filed 2023-11-14 | -$62.00K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | -$1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$704.00K 10-Q · filed 2023-08-10 | -$62.00K derived: sum of 3 quarters · filed 2023-08-10 | -$852.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $301.00K 10-Q · filed 2023-05-11 | $943.00K derived: sum of 2 quarters · filed 2023-05-11 | $153.00K derived: sum of 3 quarters · filed 2023-05-11 | $348.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $642.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | -$148.00K derived: sum of 2 quarters · filed 2023-03-24 | $47.00K derived: sum of 3 quarters · filed 2023-03-24 | $47.00K 10-K · filed 2023-03-24 |
| 2021-09-30 | -$790.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$595.00K derived: sum of 2 quarters · filed 2022-11-10 | -$595.00K 10-Q · filed 2022-11-10 | $62.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $195.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $195.00K 10-Q · filed 2022-08-11 | $852.00K derived: sum of 3 quarters · filed 2022-08-11 | |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-10 | $657.00K derived: sum of 2 quarters · filed 2022-05-10 | ||
| 2020-12-31 | $657.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | $657.00K 10-K · filed 2022-03-21 | ||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B |